MCK
McKesson Corporation · Healthcare · Medical - Distribution
Momentum inputs (comparable managers):
holder breadth -5.6% ·
share flow -22.4% ·
net new positions -5.9%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 172 | 0 | 84.73M | $64.19B | +6 | −5 |
| Q1 2026 | 174 | 0 | 86.49M | $74.72B | +5 | −6 |
| Q4 2025 | 173 | +2 | 91.21M | $74.82B | +3 | — |
| Q3 2025 | 22 | 0 | 48.07M | $37.12B | +1 | −2 |
| Q2 2025 | 20 | -1 | 40.25M | $29.48B | — | −1 |
| Q1 2025 | 18 | -1 | 15.05M | $10.13B | +1 | −2 |
| Q4 2024 | 19 | +1 | 15.70M | $8.94B | +1 | — |
| Q3 2024 | 17 | -1 | 9.08M | $4.48B | +1 | −2 |
| Q2 2024 | 18 | — | 11.69M | $6.82B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 2.65M | +1.0% | $1.31B | 0.1% | ▲ Add | 2 | SEC ↗ ×2 |
| 2 | Norges Bank ✦ (passive) | 2.15M | -6.0% | $1.06B | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 1.35M | -19.9% | $666.86M | 0.1% | ▼ Trim | 2 | SEC ↗ ×2 |
| 4 | Arrowstreet Capital ✦ | 1.11M | -10.2% | $548.76M | 0.5% | ▼ Trim | 2 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 844.84K | -1.5% | $412.72M | 0.6% | ▼ Trim | 2 | SEC ↗ ×5 |
| 6 | Glenview Capital ✦ | 266.94K | +0.5% | $131.98M | 2.8% | ▲ Add | 2 | SEC ↗ |
| 7 | Bridgewater Associates ✦ | 246.24K | -4.3% | $121.74M | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 98.28K | +12.6% | $48.59M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 9 | Millennium Management ✦ | 87.80K | -30.9% | $43.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | Renaissance Technologies ✦ | 87.63K | New | $43.32M | 0.1% | New | 1 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 71.95K | -50.3% | $35.57M | 0.1% | ▼ Trim | 2 | SEC ↗ ×2 |
| 12 | Adage Capital Partners ✦ | 49.30K | -69.6% | $24.38M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Gotham Asset Management ✦ | 29.81K | +44.1% | $14.74M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 25.41K | -88.4% | $12.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Wellington Management ✦ | 7.77K | -98.7% | $3.84M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 16 | Fisher Asset Management ✦ | 1.24K | +50.0% | $614,392 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Marshall Wace ✦ | 600 | -99.9% | $296,652 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Renaissance Technologies | $43.32M | 0.1% |
Exited
| Lone Pine Capital | $327.61M | was 2.7% |
| Viking Global Investors | $83.03M | was 0.3% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 2,017 holders, 102.83M shares, $85.35B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 111 sh · $98,951
Director · 301 sh · $268,590
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology